Literature DB >> 25219131

[Development of researches on acupuncture-assisted fertilization outside of China].

Ying-Ru Chen, Yi-Gong Fang, Fei Wang, Ning Zhang, Chun-Lan Jin, Li Yang, Ying-Ying Wang, Jin-Sheng Yang.   

Abstract

Increasing evidence shows that acupuncture therapy may have a role in promoting fertilization. Authors of the present paper collected the related articles in English published from January 2003 to May 2013 in databases of Ovid Medline, Maternity and Infant Care and Medline (Pubmed), and made an analysis. Results of many randomized controlled clinical trials (RCT) indicated that acupuncture intervention had a positive role in raising pregnancy rate, fetus surviving rate of the transplanted embryo, and increasing the neuropeptide Y content in the ollicular fluid in patients experiencing embryo transplantation, and in raising survival rate of zygote, conception rate of embryo transplantation, and in improving azoospermia in patients undergoing in vitro fertilization. But many systematic reviews and Meta-analysis did not support the above-mentioned conclusion of acupuncture therapy about promoting fertilization. The authors hold that despite of dominated positive outcomes of RCT for acupuncture-assisted fertilization, further well designed RCT are still warranted for providing further definite and convincing evidence.

Entities:  

Mesh:

Year:  2014        PMID: 25219131

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  2 in total

Review 1.  Effects of Acupuncture on the Outcomes of Assisted Reproductive Technology: An Overview of Systematic Reviews.

Authors:  Jin Xi; Hao Chen; Zhi-Hang Peng; Zong-Xiang Tang; Xiang Song; You-Bing Xia
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-20       Impact factor: 2.629

Review 2.  The Treatment of Complementary and Alternative Medicine on Female Infertility Caused by Endometrial Factors.

Authors:  Jing Lin; Haoyue Ma; Hang Li; Jing Han; Tingting Guo; Zhen Qin; Liyan Jia; Yuehui Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-07       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.